Press "Enter" to skip to content

Bristol-Myers Squibb buying Celgene in USD 74 bn deal

They’ll also receive one tradeable contingent value right for each Celgene share, allowing the holder to receive a payment when future regulatory milestones are hit.

Original source:

Also Read:   Oklahoma judge denies delay requests in opioid lawsuit